Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00361_DB00976_nanopub.RAYo58tCbfZYaYIBJX6Qx5_Eq9oPibHLY5SKQqkT2hehs#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00361_DB00976 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00361_DB00976 label "DDI between Vinorelbine and Telithromycin - Telithromycin, a CYP3A4 and p-glycoprotein inhibitor, may increase the Vinorelbine serum concentration and distribution in certain cells. Consider alternate therapy to avoid Vinorelbine toxicity. Monitor for changes in the therapeutic and adverse effects of Vinorelbine if Telithromycin is initiated, discontinued or dose changed. [drugbank_resource:DB00361_DB00976]" assertion.
- drugbank_resource:DB00361_DB00976 identifier "drugbank_resource:DB00361_DB00976" assertion.
- drugbank_resource:DB00361_DB00976 title "DDI between Vinorelbine and Telithromycin - Telithromycin, a CYP3A4 and p-glycoprotein inhibitor, may increase the Vinorelbine serum concentration and distribution in certain cells. Consider alternate therapy to avoid Vinorelbine toxicity. Monitor for changes in the therapeutic and adverse effects of Vinorelbine if Telithromycin is initiated, discontinued or dose changed." assertion.
- drugbank:DB00976 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00361_DB00976 assertion.
- drugbank:DB00361 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00361_DB00976 assertion.